Cotransplantation with MSCs improves engraftment of HSCs after autologous intra-bone marrow transplantation in nonhuman primates

Experimental Hematology

Volumn 37, Issue 10, 2009, Pages

  Masuda, Shigeo ^a   Ageyama, Naohide ^b   Shibata, Hiroaki ^b   Obara, Yoko ^a   Ikeda, Tamako ^a   Takeuchi, Kengo ^c   Ueda, Yasuji ^d   Ozawa, Keiya ^a   Hanazono, Yutaka ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^c CANCER INSTITUTE   (Japan)

^d CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL FATE; CELL HOMING; CELL MIGRATION; COLONY FORMING UNIT; CONTROLLED STUDY; ENGRAFTMENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; MALE; MARKER GENE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; STROMA CELL;

MACACA FASCICULARIS; PRIMATES;

EID: 70249110036     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.07.008     Document Type: Article

References (32)

1. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
2. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425 (2003) 836-841
3. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
4. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
5. Ozawa K., Sato K., Oh I., et al. Cell and gene therapy using mesenchymal stem cells (MSCs). J Autoimmun 30 (2008) 121-127
6. Plett P.A., Frankovitz S.M., and Orschell-Traycoff C.M. In vivo trafficking, cell cycle activity, and engraftment potential of phenotypically defined primitive hematopoietic cells after transplantation into irradiated or nonirradiated recipients. Blood 100 (2002) 3545-3552
7. Wynn R.F., Hart C.A., Corradi-Perini C., et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 104 (2004) 2643-2645
8. Zhong J.F., Zhan Y., Anderson W.F., et al. Murine hematopoietic stem cell distribution and proliferation in ablated and nonablated bone marrow transplantation. Blood 100 (2002) 3521-3526
9. Nakamura K., Inaba M., Sugiura K., et al. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow transplantation plus donor lymphocyte infusion. Stem Cells 22 (2004) 125-134
10. Wang J., Kimura T., Asada R., et al. SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection. Blood 101 (2003) 2924-2931
11. Mazurier F., Doedens M., Gan O.I., et al. Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 9 (2003) 959-963
12. Yahata T., Ando K., Sato T., et al. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101 (2003) 2905-2913
13. Ueda K., Hanazono Y., Shibata H., et al. High-level in vivo gene marking after gene-modified autologous hematopoietic stem cell transplantation without marrow conditioning in nonhuman primates. Mol Ther 10 (2004) 469-477
14. Frassoni F., Gualandi F., Podestà M., et al. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol 9 (2008) 831-839
15. Noort W.A., Kruisselbrink A.B., in 't Anker P.S., et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 30 (2002) 870-878
16. in 't Anker P.S., Noort W.A., Kruisselbrink A.B., et al. Nonexpanded primary lung and bone marrowderived mesenchymal cells promote the engraftment of umbilical cord blood-derived CD34(+) cells in NOD/SCID mice. Exp Hematol 31 (2003) 881-889
17. + human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood 103 (2004) 3313-3319
18. Muguruma Y., Yahata T., Miyatake H., et al. Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107 (2006) 1878-1887
19. Heim D.A., Hanazono Y., Giri N., et al. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. Mol Ther 1 (2000) 533-544
20. Tisdale J.F., Hanazono Y., Sellers S.E., et al. Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. Blood 92 (1998) 1131-1141
21. Shibata H., Hanazono Y., Ageyama N., et al. Collection and analysis of hematopoietic progenitor cells from cynomolgus macaques (Macaca fascicularis): assessment of cross-reacting monoclonal antibodies. Am J Primatol 61 (2003) 3-12
22. Kushida T., Inaba M., Ikebukuro K., et al. Comparison of bone marrow cells harvested from various bones of cynomolgus monkeys at various ages by perfusion or aspiration methods: a preclinical study for human BMT. Stem Cells 20 (2002) 155-162
23. Lataillade J.J., Clay D., Dupuy C., et al. Chemokine SDF-1 enhances circulating CD34(+) cell proliferation in synergy with cytokines: possible role in progenitor survival. Blood 95 (2000) 756-768
24. Lataillade J.J., Clay D., Bourin P., et al. Stromal cell derived factor 1 regulates primitive hematopoiesis by suppressing apoptosis and by promoting G(0)/G(1) transition in CD34(+) cells: evidence for an autocrine/paracrine mechanism. Blood 99 (2002) 1117-1129
25. Cashman J., Clark-Lewis I., Eaves A., and Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood 99 (2002) 792-799
26. Oh I., Ozaki M., Miyazato A., et al. Screening of genes responsible for differentiation of mouse mesenchymal stromal cells by DNA micro-array analysis of C3H10T1/2 and C3H10T1/2-derived cell lines. Cytotherapy 9 (2007) 80-90
27. Koç O.N., Gerson S.L., Cooper B.W., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
28. Lazarus H.M., Koc O.N., Devine S.M., et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant 11 (2005) 389-398
29. Ball L.M., Bernardo M.E., Roelofs H., et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110 (2007) 2764-2767
30. Yamamura K., Ohishi K., Masuya M., et al. Ex vivo culture of human cord blood hematopoietic stem/progenitor cells adversely influences their distribution to other bone marrow compartments after intra-bone marrow transplantation. Stem Cells 26 (2008) 543-549
31. Larochelle A., Choi U., Shou Y., et al. In vivo selection of hematopoietic progenitor cells and temozolomide dose intensification in rhesus macaques through lentiviral transduction with a drug resistance gene. J Clin Invest 119 (2009) 1952-1963
32. Zhang X.B., Beard B.C., Beebe K., Storer B., Humphries R.K., and Kiem H.P. Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells. PLoS Med 3 (2006) e173